Clinuvel Pharmaceuticals Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: 0.050x

Clinuvel Pharmaceuticals Ltd cash flow conversion efficiency. Based on the latest financial reports, Clinuvel Pharmaceuticals Ltd (CUV) has a cash flow conversion efficiency ratio of 0.050x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$12.52 Million ≈ $8.86 Million USD) by net assets (AU$249.02 Million ≈ $176.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Clinuvel Pharmaceuticals Ltd (2001–2025)

Cash flow conversion efficiency of Clinuvel Pharmaceuticals Ltd from 2001 to 2025. This chart illustrates how Clinuvel Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Clinuvel Pharmaceuticals Ltd for real-time trading data and today's change.

Clinuvel Pharmaceuticals Ltd Cash Flow Conversion Ratio Explained

Clinuvel Pharmaceuticals Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Clinuvel Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Clinuvel Pharmaceuticals Ltd ranked by their cash flow conversion efficiency. Also see CUV market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Beijing Piesat Information Technology Co Ltd SHG:688066	0.072x
Ratnaveer Precision Engineering Ltd NSE:RATNAVEER	-0.005x
Jiangsu Huaxin New Material Co Ltd Class A SHE:300717	0.035x
Tongxing Environmental Protection SHE:003027	0.056x
Duopharma Biotech Bhd KLSE:7148	0.003x
KPM TECH Co. Ltd KQ:042040	0.241x
Fusion Micro Finance Limited NSE:FUSION	0.221x
Profound Medical Corp TO:PRN	-0.222x

Annual Cash Flow Conversion Efficiency for Clinuvel Pharmaceuticals Ltd (2001–2025)

The table below shows the annual cash flow conversion efficiency of Clinuvel Pharmaceuticals Ltd from 2001 to 2025. Review CUV cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$240.81 Million ≈ $170.39 Million	AU$41.10 Million ≈ $29.08 Million	0.171x	-6.50%
2024-06-30	AU$203.01 Million ≈ $143.64 Million	AU$37.05 Million ≈ $26.22 Million	0.183x	-18.59%
2023-06-30	AU$164.63 Million ≈ $116.49 Million	AU$36.91 Million ≈ $26.12 Million	0.224x	-29.40%
2022-06-30	AU$125.56 Million ≈ $88.84 Million	AU$39.87 Million ≈ $28.21 Million	0.318x	+62.78%
2021-06-30	AU$98.74 Million ≈ $69.86 Million	AU$19.26 Million ≈ $13.63 Million	0.195x	-0.91%
2020-06-30	AU$72.07 Million ≈ $50.99 Million	AU$14.19 Million ≈ $10.04 Million	0.197x	-39.00%
2019-06-30	AU$57.18 Million ≈ $40.46 Million	AU$18.46 Million ≈ $13.06 Million	0.323x	+8.80%
2018-06-30	AU$39.42 Million ≈ $27.89 Million	AU$11.69 Million ≈ $8.27 Million	0.297x	-23.88%
2017-06-30	AU$25.44 Million ≈ $18.00 Million	AU$9.92 Million ≈ $7.02 Million	0.390x	+238.00%
2016-06-30	AU$17.83 Million ≈ $12.62 Million	AU$-5.04 Million ≈ $-3.56 Million	-0.282x	+30.14%
2015-06-30	AU$11.21 Million ≈ $7.93 Million	AU$-4.53 Million ≈ $-3.21 Million	-0.404x	-29.70%
2014-06-30	AU$15.43 Million ≈ $10.92 Million	AU$-4.81 Million ≈ $-3.40 Million	-0.312x	+37.41%
2013-06-30	AU$13.84 Million ≈ $9.79 Million	AU$-6.89 Million ≈ $-4.88 Million	-0.498x	+32.24%
2012-06-30	AU$13.64 Million ≈ $9.65 Million	AU$-10.02 Million ≈ $-7.09 Million	-0.735x	-27.11%
2011-06-30	AU$16.41 Million ≈ $11.61 Million	AU$-9.49 Million ≈ $-6.71 Million	-0.578x	-29.67%
2010-06-30	AU$26.43 Million ≈ $18.70 Million	AU$-11.78 Million ≈ $-8.34 Million	-0.446x	-50.38%
2009-06-30	AU$37.05 Million ≈ $26.22 Million	AU$-10.99 Million ≈ $-7.77 Million	-0.296x	-113.93%
2008-06-30	AU$51.81 Million ≈ $36.66 Million	AU$-7.18 Million ≈ $-5.08 Million	-0.139x	-10.81%
2007-06-30	AU$65.39 Million ≈ $46.27 Million	AU$-8.18 Million ≈ $-5.79 Million	-0.125x	+84.66%
2006-06-30	AU$13.99 Million ≈ $9.90 Million	AU$-11.40 Million ≈ $-8.07 Million	-0.815x	+34.28%
2005-06-30	AU$7.45 Million ≈ $5.27 Million	AU$-9.25 Million ≈ $-6.54 Million	-1.240x	-82.98%
2004-06-30	AU$8.85 Million ≈ $6.27 Million	AU$-6.00 Million ≈ $-4.25 Million	-0.678x	-180.66%
2002-06-30	AU$10.31 Million ≈ $7.29 Million	AU$-2.49 Million ≈ $-1.76 Million	-0.242x	-531.42%
2001-06-30	AU$13.45 Million ≈ $9.52 Million	AU$-514.54K ≈ $-364.07K	-0.038x	--

About Clinuvel Pharmaceuticals Ltd

AU:CUV Australia Biotechnology

Market Cap

$268.32 Million

AU$379.22 Million AUD

Market Cap Rank

#15047 Global

#400 in Australia

Share Price

AU$7.52

Change (1 day)

-2.84%

52-Week Range

AU$7.01 - AU$13.23

All Time High

AU$44.55